By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Blumenstra├če 16

Freising-Weihenstephan    85354  Germany
Phone: 49-0-8161-71-389 Fax: 49-0-8161-71-3484



Company News
Pieris Surged on $82.75 Million Anemia Drug Deal 2/28/2017 7:02:48 AM
Tiny Boston Biotech Pieris Nabs $570 Million+ Cancer Deal With French Powerhouse Servier 1/5/2017 6:07:19 AM
Selexis SA Enters Into Commercial Cell Line License Agreement With Pieris For Immuno-Oncology Bispecific Drug Candidate 9/7/2016 11:31:18 AM
Enumeral Biomedical (ENUM) Receives Maintenance Fee To Continue License Agreement With Pieris And Enters Into Definitive License Agreement 6/6/2016 11:56:48 AM
Bay State's Enumeral Biomedical (ENUM) Signs $106.3 Million+ Immuno-Cancer Deal With Pieris 4/18/2016 6:08:38 AM
Pieris To Present At The 18th Annual BIO CEO And Investor Conference On February 8th At 9:30 am ET 1/28/2016 10:58:17 AM
Pieris Wrangles a $409.3 Million+ Cancer Immunotherapy Deal from Drug Giant Roche (RHHBY) 12/8/2015 5:54:12 AM
Pieris CEO Stephen S. Yoder To Be Interviewed On "The Big Biz Show" On September 23rd At 3:50 pm EDT 9/24/2015 12:20:45 PM
Forbion Announces Two Successful Initial Public Offerings Of Portfolio Companies Pieris And Cellnovo 8/12/2015 9:11:18 AM
Pieris Achieves Milestone Payment In Daiichi Sankyo, Inc. (4568.t) Collaboration To Develop Anticalin┬« Therapeutics 6/23/2014 8:51:22 AM